Get the latest information about funding opportunities and resources from the National Cancer Institute! Program Directors from the National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center will be presenting funding opportunities and other resources for startups in cancer technology. You will also learn about 12 new targeted funding opportunities in cancer detection, diagnosis, and treatment in high priority areas of research for the NCI. Other topics to be covered include tips on application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will review the many initiatives run by NCI to facilitate the success of SBIR companies.
2:00 PM – 3:00 PM Presentation: NCI SBIR/STTR Overview and Initiatives
3:00 PM –3:30 PM Q&A
Xing-Jian Lou, Program Director, NCI SBIR Development Center
Dr. Xing-Jian Lou is a Program Director in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI). In this role, she actively engages in identifying areas of interest for NCI to develop Contract Topics and Funding Opportunity Announcements. She also guides small businesses to develop stronger applications and obtain government funding for innovative research and development projects with high commercial potential. Dr. Lou manages funded projects, mentoring and guiding companies throughout the award period, and facilitating their interaction with potential third-party investors and strategic partners. Dr. Lou has over 15 years experience in research and product development in the area of biomarker-, assay-, technology- and knowledgebase- development for diagnosis and drug development. Prior to joining NCI she held a variety of scientific and management positions in pharmaceutical and biotech companies, including Johnson & Johnson, LumiCyte, Applied Biosystems (now part of Thermo Fisher Scientific corporation) and diaDexus. Dr. Lou received her PhD degree in Molecular & Cellular Pharmacology from the Miller Medical School of the University of Miami and completed her postdoctoral training at Stanford University.
Jonathan Franca-Koh, Program Director, NCI SBIR Development Center
Dr. Jonathan Franca-Koh is a Program Director at the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center. Jonathan manages SBIR & STTR grants and contracts with a focus on cancer therapeutics and novel tools for research and drug discovery. He provides oversight throughout the award period and mentors applicants and awardees in developing their technology goals and commercialization strategy. Additionally, he plays an active role in several center initiatives, including recent investor forums, workshops, targeted funding opportunities, and represents the NCI on the trans-NIH REACH program. Prior to joining the SBIR Development Center, Jonathan was a Program Director at the NCI Division of Cancer Biology and Center for Strategic Scientific Initiatives, overseeing the Physical Sciences-Oncology Centers (PS-OC) program, a network of interdisciplinary centers that brought together physical scientists and cancer biologists. Jonathan received his PhD in Cell and Molecular Biology from the University of London’s Institute of Cancer Research in 2003, and completed post-doctoral research at Johns Hopkins University and the J. Craig Venter Institute. In 2014 he completed his MBA from Johns Hopkins University, focusing on finance and health care innovation.